GSE146358 dopamine 5 v 2 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE146358_dopamine_5_v_2_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE146358_dopamine_5_v_2_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE146358_dopamine_5_v_2_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE146358_dopamine_5_v_2_human_up.

Results found

Linked to

 

Label

Description

 

Gene

differentiation antagonizing non-protein coding RNA

Gene

GOLGA2 pseudogene 7

Gene

MIR1915 host gene

Gene

long intergenic non-protein coding RNA 3040

Gene

urothelial cancer associated 1

Gene

endogenous Bornavirus like nucleoprotein 3, pseudogene

Gene

GABPB1 intronic transcript

Gene

small nucleolar RNA host gene 33

Gene

long intergenic non-protein coding RNA 1234

Gene

fer-1 like family member 4 (pseudogene)

  • Gene

    differentiation antagonizing non-protein coding RNA


  • Gene

    GOLGA2 pseudogene 7



  • Gene

    long intergenic non-protein coding RNA 3040


  • Gene

    urothelial cancer associated 1


  • Gene

    endogenous Bornavirus like nucleoprotein 3, pseudogene


  • Gene

    GABPB1 intronic transcript


  • Gene

    small nucleolar RNA host gene 33


  • Gene

    long intergenic non-protein coding RNA 1234


  • Gene

    fer-1 like family member 4 (pseudogene)

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.